Colorado State University link College of Veterinary Medicine and Biomedical Sciences link College of Veterinary Medicine and Biomedical Sciences logo
   CSU Home     Search CSU    CVMBS Home     Site Index     Students     RamCT  

 

Colorado mountainsDow Laboratory

Selected Early and Recent Publications

Pub Med for Dow S.

  1. Dow SW, Liggitt DL, Fradkin L, and Potter TA. (1999) Potent immune activation and antitumor immunity induced by intravenous administration of cationic lipid-DNA complexes. J Immunol 163:1552-1561.
  2. Bosio C and Dow S. (2005) Aberrant activation of pulmonary dendritic cells by Francisella tularensis. J Immunol 175:6792-6801.
  3. U’Ren L, Kedl R, and Dow S. (2006) Immunization with liposome-DNA complexes elicits enhanced antitumor immunity. Cancer Gene Ther, 13:1033-
  4. Zaks K, Jordan M, Guth A, Sellins K, Kedl R, Izzo A, Bosio C, and Dow S. (2006) Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 and TLR9 agonists complexed to cationic liposomes. J Immunol, 176:7335-7345.
  5. Elmslie R, Glawe P, and Dow S. (2009) Metronomic chemotherapy with cytoxan and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcoma, J Vet Intern Med, 22:1373-1379.
  6. Takeda T, Dow S, Miyahara N, Kodama T, Koya T, Taube C, Joetham A, Park J, Dakhama A, Kedl R, and Gelfand E. (2009) Vaccine-induced CD8+ T cell suppression of airway hyper-responsiveness and inflammation. J Immunol, 183:181-190.
  7. Guth A, Bosio C, Janssen W, Crouch E, Henson P, and Dow S. (2009) Lung environment determines unique phenotype of alveolar macrophages.  J. Physiol Lung Cell Mol Biol; 296:L936-946.
  8. Goodyear A, Troyer R, Jones A, and Dow S. (2009) Protection from Burkholderia infection by inhalational immunotherapy.  Infection and Immunity 77:1759-1765.
  9. Troyer R, Propst K, Fairman, J, Bosio K, and Dow S. (2009) Mucosal immunotherapy for protection from pneumonic Francisella infection. Vaccine 27:4424-4433.
  10. Sottnik J, Guth A, Thamm D, and Dow S. (2010) Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses. Cancer Immunol Immunother 59:367-375.
  11. Goodyear A, Jones A, Troyer R, and Dow S.  (2010) Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection.  J Immunol 184:1445-1454.
  12. Propst K, Troyer R, Kellihan L, Schweizer H, and Dow S. (2010)  Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection.  Antimicrob Agents Chemoth 54:1785-1792.
  13. U’Ren L, Guth A, and Dow S. (2010) Type I interferons inhibit the generation of tumor associated macrophages.  Cancer Immunol Immunoth 59:587-592.
  14. Jones A, Bosio C, Duffy A, Goodyear A, Schriefer M, and Dow S. (2010) Protection against pneumonic plague following oral immunization with a non-replicating vaccine.  Vaccine 28:5924.
  15. Sottnik J, Rao S, Lafferty M, Withrow S, and Dow S. (2010) Association of blood monocyte and lymphocyte count and disease-free interval in dogs with osteosarcoma. J Vet Intern Med, 24:1439.
  16. Perry J, Thamm D, Avery A, and Dow S. (2011).  Increased monocyte chemoattractant protein-1 concentrations and monocyte count independent associate with reduced survival in dogs with lymphoma.  Vet Comp Oncol 9:55.
  17. Quimby J, Gibbons D, Webb T, and Dow S. (2011).  Evaluation of intra-renal mesenchymal stem cell injection for chronic kidney disease in cats: a pilot study. J Fel Med Surg, in press.